• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱移行细胞癌的管理

Management of transitional cell carcinoma of the bladder.

作者信息

Murshidi M S

出版信息

Arch Esp Urol. 1989 Mar;42(2):172-5.

PMID:2735783
Abstract

A six years experience in the management of 33 Jordanian patients with transitional cell carcinoma of the urinary bladder is reported. They were treated by transurethral resection for superficial tumours, invasive tumours were treated by radiotherapy and resection, cystectomy was done for invasive cancer which did not respond to radiotherapy and resection, and urinary diversion was done for inoperable tumours. This treatment was suitable for these 33 patients medically and socially, and it gave similar results in comparison with other centres.

摘要

本文报道了对33例约旦膀胱移行细胞癌患者进行管理的六年经验。浅表肿瘤采用经尿道切除术治疗,浸润性肿瘤采用放疗和切除术治疗,对放疗和切除术无反应的浸润性癌行膀胱切除术,对无法手术的肿瘤行尿流改道术。这种治疗方法在医学和社会方面适用于这33例患者,与其他中心相比,其结果相似。

相似文献

1
Management of transitional cell carcinoma of the bladder.膀胱移行细胞癌的管理
Arch Esp Urol. 1989 Mar;42(2):172-5.
2
Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.新辅助放疗对浸润性膀胱癌患者膀胱切除术前降期及生存获益情况
Scand J Urol Nephrol. 2009;43(4):293-9. doi: 10.1080/00365590902854313.
3
An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.一种用于肌层浸润性膀胱癌的联合动脉内化疗和放疗的保留器官治疗方法。
Scand J Urol Nephrol. 2002;36(5):339-43. doi: 10.1080/003655902320783836.
4
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?卡介苗治疗非肌层浸润性膀胱癌后复发的同步放化疗结果:是否总是需要立即进行膀胱切除术?
BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.
5
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.复发性高危浅表性膀胱肿瘤患者根治性膀胱切除术的最佳时机。
BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x.
6
T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.膀胱T2a期移行细胞癌:卡介苗膀胱内免疫预防的长期经验
J Urol. 2003 Mar;169(3):931-4; discussion 934-5. doi: 10.1097/01.ju.0000049002.75782.39.
7
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
8
Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?经尿道切除术后高危T1期膀胱癌的放化疗:膀胱内灌注治疗或早期膀胱切除术的替代方案?
J Clin Oncol. 2006 May 20;24(15):2318-24. doi: 10.1200/JCO.2006.05.8149.
9
The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.局部晚期膀胱癌患者接受新辅助化疗、广泛经尿道切除术及放疗的保守治疗结局:10年经验
J Urol. 1998 Apr;159(4):1187-91.
10
Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.二次病理会诊意见对膀胱癌患者最终治疗的影响。
Cancer. 2001 Apr 1;91(7):1284-90.

引用本文的文献

1
A Systematic Review of Animal Models of Disuse-Induced Bone Loss.废用性骨质流失动物模型的系统评价
Calcif Tissue Int. 2021 May;108(5):561-575. doi: 10.1007/s00223-020-00799-9. Epub 2021 Jan 1.